Anesthesia for magnetic resonance imaging in children: a survey of Canadian pediatric centres
To the Editor: We recently conducted a telephone survey of pediatric anesthesia departments in 11 Canadian university centres. Department chiefs (or designates) were asked to identify current anesthesia practice and concerns for pediatric magnetic resonance imaging (MRI). In all 11 centres, care was provided by pediatric anesthesiologists, with ten centres having MRI compatible machines available. All centres routinely used capnography and pulse oximetry. Eight centres routinely used non-invasive blood pressure monitoring. Five centres routinely used electrocardiogram (ECG) monitoring, and two centres had no MRI compatible ECG available. In seven centres the anesthesiologists were located in the control room during scanning. Staff were more likely to remain in the scanning room if a slave monitor was unavailable in the control room.
Six centres predominantly used a propofol total iv anesthesia technique (TIVA), with the other five centres using a volatile technique more frequently or exclusively. Centres predominantly using TIVA were less likely to instrument the airway (Table) . Propofol induction and maintenance dose estimates ranged from 2 to 6 mg·kg -1 (mean 3.7) and 100 to 250 µg·kg -1 ·min -1 (mean 165) respectively, with one centre using boluses as required rather than an infusion. Three centres routinely using TIVA had no MRI compatible infusion pump available; instead using a remote pump with a hydraulic interface, or a manual method calculating drops per minute. Propofol sedation techniques have been well described previously, although often with lower doses of propofol than we found in this survey. [1] [2] [3] Centres not routinely using TIVA had concerns about maintaining and monitoring the airway if nasal prongs or a face mask were used.
Annual caseload estimates ranged from 20 to 1,400 children. Many centres noted increasing demand from radiology departments for anesthesia services, with one centre commenting that anesthesia out of the operating room currently accounts for greater than 30% of the department workload. Most centres felt that seven to eight years was the age at which children more reliably tolerated scanning without anesthesia. The mean daily caseload for centres predominantly using TIVA was 9.2 (5-12) vs 7.2 (5-10) for other centres, possibly due to shorter induction and emergence periods as the airway is instrumented less often.
We conclude that anesthesia for MRI accounts for a significant workload for pediatric anesthesiologists. Some centres remain concerned about the safety of TIVA using nasal prongs or face mask despite the suggestion it may decrease anesthesia time. 
Lafutidine vs cimetidine to decrease gastric fluid acidity and volume in children
To the Editor: General anesthesia carries a risk for aspiration pneumonitis. 1 Histamine H 2 receptor antagonists have been administered to minimize the risk of acid aspiration syndrome by decreasing gastric secretion. 2 In the CORRESPONDENCE 425 current study, we compared the effects of oral lafutidine, a new potent and long-acting H 2 antagonist, with cimetidine on preoperative gastric fluid pH and volume in children. One hundred and fifty non-sedated patients (4-15 yr) were given the study medications the evening before surgery and three hours before anesthesia. The groups (n = 30 each) were lafutidine + lafutidine, lafutidine + placebo, placebo + lafutidine, placebo + cimetidine, and placebo + placebo. The fixed single doses of lafutidine and cimetidine were 5 mg and 200 mg, respectively. After induction of anesthesia and tracheal intubation, gastric fluid was manually aspirated through a multiorifice orogastric tube and analyzed for volume and pH (Advantec pH test papers). Lafutidine at any timing and cimetidine three hours prior to induction of anesthesia decreased gastric fluid volume and acidity, and thereby reduced the number of children with gastric fluid pH 2.5 and volume $ 0.4 mL·kg -1 (Table) . The potency of lafutidine is 2.3 times that of cimetidine. 4 In the current study, however, improvement of preoperative gastric contents was similar between both drugs. The size of the groups may have been insufficient to detect intergroup differences. We used a fixed dose of lafutidine or cimetidine to simplify preparation of the drugs. Prescription of dose per body weight may have reduced the interindividual variability in the effectiveness of the drugs. Timing of the morning dose (three hours before anesthesia) was based on the pharmacokinetic characteristics (Tmax = one hour) of lafutidine and rapid onset (one hour) of antisecretory action. Our results suggest that, in children scheduled for elective surgery, the reduction in gastric fluid volume and acidity by lafutidine or cimetidine can reasonably be anticipated to provide protection against the occurrence of pneumonitis, should regurgitation and aspiration of gastric contents occur. Further studies are required to assess the prophylactic role of lafutidine in pediatric patients who may be predisposed to pulmonary aspiration (e.g., ASA IV or V, emergency, surgery, a recent meal, 5 etc. Values are expressed as mean ± SD and [range] (n = 30 for each group). N0 = number of patients in whom gastric fluid was 0 mL. ¶Risk = percentage of patients deemed at risk for aspiration pneumonitis (gastric fluid pH of # 2.5 and volume of $ 0.4 mL·kg -1 ). 3 Data were analyzed using Kruskal-Wallis rank test followed by Tukey-Kramer post-hoc test (pH and volume; non-normal distribution) and Fisher's exact test (proportions of risk). *P < 0.05 vs control group. All intervention groups gave a similar significant decrease in pH and volume compared to placebo; no inter-group difference was significant between the various interventions. L+L = lafutidine + lafutidine; L+P = lafutidine + placebo; P+L = placebo + lafutidine; P+C = placebo + cimetidine; P+P = placebo + placebo.
